Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.
Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA. Lee O, et al. Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045. Clin Cancer Res. 2014. PMID: 25028506 Free PMC article. Clinical Trial.
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.
Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC. Khan SA, et al. Among authors: hansen nm. Cancer Prev Res (Phila). 2012 Feb;5(2):309-19. doi: 10.1158/1940-6207.CAPR-11-0251. Cancer Prev Res (Phila). 2012. PMID: 22307566 Free PMC article. Clinical Trial.
Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate.
Lee O, Sullivan ME, Xu Y, Rogers C, Muzzio M, Helenowski I, Shidfar A, Zeng Z, Singhal H, Jovanovic B, Hansen N, Bethke KP, Gann PH, Gradishar W, Kim JJ, Clare SE, Khan SA. Lee O, et al. Among authors: hansen n. Clin Cancer Res. 2020 Jan 1;26(1):25-34. doi: 10.1158/1078-0432.CCR-19-0443. Epub 2019 Sep 30. Clin Cancer Res. 2020. PMID: 31570566 Clinical Trial.
Effect of MRI on the management of ductal carcinoma in situ of the breast.
Pilewskie M, Kennedy C, Shappell C, Helenowski I, Scholtens D, Hansen N, Bethke K, Jeruss J, Karstaedt P, Khan SA. Pilewskie M, et al. Among authors: hansen n. Ann Surg Oncol. 2013 May;20(5):1522-9. doi: 10.1245/s10434-012-2771-y. Epub 2012 Dec 7. Ann Surg Oncol. 2013. PMID: 23224903
1,337 results